San Francisco, United States
Phizzle is a market leader in automating and digitizing scientific lab instruments used in pharmaceutical and other clean manufacturing environments. The company, founded in 2005, is a first-mover in the market, offering a patented IoT solution that can remotely operate multiple types and vendors of lab instruments from the cloud. It has a recurring revenue contract with a Fortune 75 company and is FDA-compliant in its use case, which is the first of its kind. Phizzle's slogan, "Bringing the power of automation to pharmaceutical manufacturing," and its focus on bringing automation to an industry typically reliant on manual processes positions it as an innovative player in the market.
The recent $4.60M Convertible Note investment in March 31, 2017 from Agility Capital has provided the company with the necessary funds to further develop and commercialize its technology. This investment underscores investor confidence in Phizzle's potential to disrupt and innovate the pharmaceutical and clean manufacturing industry sectors. The company's presence in the United States, coupled with its diverse applications across industries such as pharmaceutical, transportation, and oil and gas, showcases its potential for widespread impact and growth.
Phizzle's ability to bridge the gap between traditional lab equipment and modern technological solutions, as well as its strategic partnerships and proven track record, make it an attractive prospect for VC investors seeking opportunities in the digital transformation of traditional industries.
